1. Home
  2. CMPS vs TALK Comparison

CMPS vs TALK Comparison

Compare CMPS & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • TALK
  • Stock Information
  • Founded
  • CMPS 2020
  • TALK 2012
  • Country
  • CMPS United Kingdom
  • TALK United States
  • Employees
  • CMPS N/A
  • TALK N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • TALK Medical/Nursing Services
  • Sector
  • CMPS Health Care
  • TALK Health Care
  • Exchange
  • CMPS Nasdaq
  • TALK Nasdaq
  • Market Cap
  • CMPS 487.4M
  • TALK 442.1M
  • IPO Year
  • CMPS 2020
  • TALK N/A
  • Fundamental
  • Price
  • CMPS $6.34
  • TALK $2.72
  • Analyst Decision
  • CMPS Strong Buy
  • TALK Buy
  • Analyst Count
  • CMPS 7
  • TALK 6
  • Target Price
  • CMPS $17.00
  • TALK $4.50
  • AVG Volume (30 Days)
  • CMPS 1.5M
  • TALK 1.0M
  • Earning Date
  • CMPS 10-30-2025
  • TALK 10-28-2025
  • Dividend Yield
  • CMPS N/A
  • TALK N/A
  • EPS Growth
  • CMPS N/A
  • TALK N/A
  • EPS
  • CMPS N/A
  • TALK 0.02
  • Revenue
  • CMPS N/A
  • TALK $202,611,000.00
  • Revenue This Year
  • CMPS N/A
  • TALK $22.35
  • Revenue Next Year
  • CMPS N/A
  • TALK $21.66
  • P/E Ratio
  • CMPS N/A
  • TALK $166.40
  • Revenue Growth
  • CMPS N/A
  • TALK 17.43
  • 52 Week Low
  • CMPS $2.25
  • TALK $2.22
  • 52 Week High
  • CMPS $6.63
  • TALK $4.36
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 73.27
  • TALK 53.22
  • Support Level
  • CMPS $5.54
  • TALK $2.66
  • Resistance Level
  • CMPS $6.62
  • TALK $2.86
  • Average True Range (ATR)
  • CMPS 0.33
  • TALK 0.11
  • MACD
  • CMPS 0.08
  • TALK 0.01
  • Stochastic Oscillator
  • CMPS 86.39
  • TALK 44.59

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: